MK-1064 is a potent, selective and orally active Orexin OX2 Receptor Antagonist for potential treatment of insomnia.
For research use only. We do not sell to patients.
Name | MK-1064 |
---|---|
Iupac Chemical Name | 5-(5-Chloro-3-pyridyl)-N-((5,6-dimethoxy-2-pyridyl)methyl)-2-(2-pyridyl)pyridine-3-carboxamide |
Synonyms | MK1064; MK-1064; MK 1064 |
Molecular Formula | C24H20ClN5O3 |
Molecular Weight | 461.906 |
Smile | ClC=1C=C(C=NC1)C=1C=C(C(=NC1)C1=NC=CC=C1)C(=O)NCC1=NC(=C(C=C1)OC)OC |
InChiKey | CKTWQGHVNRYNCM-UHFFFAOYSA-N |
InChi | InChI=1S/C24H20ClN5O3/c1-32-21-7-6-18(30-24(21)33-2)14-29-23(31)19-10-16(15-9-17(25)13-26-11-15)12-28-22(19)20-5-3-4-8-27-20/h3-13H,14H2,1-2H3,(H,29,31) |
CAS Number | 1207253-08-4 |
Related CAS | 1207253-08-4 |
Packaging | Price | Availability | Purity | Shipping Time |
---|---|---|---|---|
Bulk | Enquiry | Enquiry | Enquiry |
Formulation | Off-white Solid |
---|---|
Purity | ≧98.0% |
Storage | 3 years -20ºCpowder |
Solubility | Soluble in DMSO |
Handling | Avoid inhalation, contact with eyes and skin. Avoid dust and aerosol formation. Use only in areas with appropriate exhaust ventilation. |
Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. |
HS Code |
Targets | |
---|---|
Mechanism | |
Cell study | |
Animal study | |
Clinical study |